Participant flow12

How many started, completed or left each group, period by period.

1 to 12 of 12

Period	Milestone	Group	Participants
Overall Study	STARTED	Sapropterin Dihydrochloride	96
Overall Study	STARTED	Placebo	94
Overall Study	Intent to Treat	Sapropterin Dihydrochloride	87
Overall Study	Intent to Treat	Placebo	83
Overall Study	Per-protocol	Sapropterin Dihydrochloride	69
Overall Study	Per-protocol	Placebo	69
Overall Study	Safety Population	Sapropterin Dihydrochloride	97
Overall Study	Safety Population	Placebo	91
Overall Study	COMPLETED	Sapropterin Dihydrochloride	81
Overall Study	COMPLETED	Placebo	80
Overall Study	NOT COMPLETED	Sapropterin Dihydrochloride	15
Overall Study	NOT COMPLETED	Placebo	14

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT00403494/flow